Endocrine Adverse Events Related To Immune Checkpoint Inhibitor Treatment: Relationship Between Antibodies and Severity of Thyroid Dysfunction

María Miguélez González; Alba Galdón Sanz-Pastor; Roberto Áñez Gómez; Noemí Brox Torrecilla; Diego Muñoz Moreno; Laura González Fernández; Alejandra Maricel Rivas; Aurelio López Guerra; Rosa Álvarez; José Ángel Arranz; Iván Márquez‐Rodas; V Escudero; María Sanjurjo‐Sáez; Javier Martín‐Vallejo; Miguel Martín; Olga González Albarrán

doi:10.2174/0118715303280679240206100137

February 16, 2024Endocrine Metabolic & Immune Disorders - Drug Targets

Endocrine Adverse Events Related To Immune Checkpoint Inhibitor Treatment: Relationship Between Antibodies and Severity of Thyroid Dysfunction

View at Publisher

Ask AI

Bookmark

Share

Abstract

This is the authors' abstract. We don't add key points for this paper.

The purpose of this study was to identify predictive and risk factors for the development of immune-related endocrinopathies and to analyze the incidence and characteristics of immune-related endocrinopathies in our population.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

González et al. (2024) studied this question.

synapsesocial.com/papers/68e78e33b6db6435876ffc05 https://doi.org/10.2174/0118715303280679240206100137

View at Publisher

Ask AI

Bookmark

Share

Endocrine Adverse Events Related To Immune Checkpoint Inhibitor Treatment: Relationship Between Antibodies and Severity of Thyroid Dysfunction

Abstract

Ask about this paper

Discussion

Cite This Study

Endocrine Adverse Events Related To Immune Checkpoint Inhibitor Treatment: Relationship Between Antibodies and Severity of Thyroid Dysfunction

Abstract

Ask about this paper

Discussion

Cite This Study

Keep reading

Keep reading